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Abstract 
Purpose: To investigate the antitumor activity of physcion8-O-β-glucopyranoside (PSG) against cervical 
cancer, as well as its mechanisms. 
Methods: The anti-proliferative effects of PSG on HeLa cells were determined by CCK-8 assay and the 
half maximal inhibitory concentration (IC50) values were calculated. Subsequently, a mouse xenograft 
model of HeLa cell line was established to investigate the antitumor effect of PSG in vivo. Furthermore, 
cell apoptosis was investigated by fluorescence microscopy via DAPI staining, and other mechanisms 
were determined by Western blot assay. 
Results: In vitro, PSG exhibited significant anti-proliferative effect on HeLa cells (p <0.05) in 
concentration-and time-dependent manners, with an IC50 value of 41.34 μg/mL. In vivo, PSG also had 
significant anti-tumor activity in nude mouse xenograft model (p < 0.05), inhibiting tumor growth. 
Furthermore, the results showed that treatment with PSG (20, 40 and 60 μg/mL) for 24 h resulted in 
significantly increased apoptosis in HeLa cells (p < 0.05). Additionally, Western blot analysis revealed 
that after exposure to 20, 40 and 60 μg/mL of PSG for 24 h, protein expressions of C-caspase-3, C-
caspase-9 and Bax were markedly up-regulated (p < 0.05) while Bcl-2 was significantly down-regulated 
(p < 0.05). These results confirmed that PSG inhibited HeLa cell growth by inducing mitochondria-
mediated apoptosis via up-regulation of caspase-3 and caspase-9 and Bax, and down-regulation of Bcl-
2. 
Conclusion: The results demonstrate that PSG possesses notable anti-tumor activity against cervical 
cancer and that the mechanisms involve induction of apoptosis by mitochondria-mediated signaling 
pathway. 
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In spite of the improvements that have been 
achieved in diagnostic and screening techniques, 
cervical cancer still remains the fourth leading 
cause of cancer related deaths among women 
worldwide and the second cause of deaths 
among women in developing countries [1,2]. The 
average age of patients with recurrent cervical 
carcinoma is about 40 - 45 years [3]. In addition, 
the recurrence for stages III and IVA is 42 and 74 
%, respectively. At present, chemotherapy or 
neoadjuvant chemotherapy is always the first 
choice for those patients with advanced cervical 
cancer, whereas the overall survival remains 
poor [4]. Therefore, there is an urgent need to 
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find effective drugs or therapeutic methods to 
treat cervical cancer. It has been reported that 
natural products derived from plants and 
microorganisms have anticancer activities, which 
provide useful clues for discovering new 
anticancer drugs. 
 
Physcion 8-O-β-glucopyranoside (PSG) is an 
anthraquinone (Fig 1) extracted from Rumex 
japonicas Houtt [5]. Rumex japonicas Houtt, a 
perennial herb plant belonging to the family 
Polygonaceae, is widely distributed in China and 
recorded [6]. It has been traditionally used in folk 
medicine for relieving bowel movement, stopping 
bleeding and as an antipruritic agent [6]. At 
present, it is recognized that R. japonicas has 
new pharmacological activities such as anti-
microorganic, anti-oxidant, anti-inflammatory and 
anti-tumor [7-10]. In addition, a large number of 
bioactive compounds have been found in R. 
japonicas, including anthraquinones, emodin, 
chrysophanol, physcion, fatty acids, condensed 
tannins, and so on [11-13].  
 
PSG is one of the major bioactive compounds 
present in R. japonicas, and has been reported 
to have significant anti-proliferative activity on 
A549 cell lines by inducing apoptosis and cell 
cycle arrest [5]. However, to the best of our 
knowledge, the anti-cervical cancer effects of 
PSG isolated from R. japonicas has not been 
researched at present. In our present work, we 
focus on the anti-tumor effect of PSG in human 
cervical cancer cell line HeLa in vitro and in vivo, 
and explore the possible mechanisms, which 
may provide a scientific basis for treating this 











Figure 1: Structure of physcion 8-O-β-






Physcion 8-O-β-glucopyranoside (PSG) was 
purchased from the Sichuan Keluoma Biotech. 
Co. (Chengdu, China) and was isolated from the 
dry root of R. japonicas with purity of more than 
98 %. Dulbecco's Modified Eagle Medium 
(DMEM) and fetal bovine serum (FBS) were 
purchased from Life Technologies Inc (Gibco 
BRL); Penicillin-Streptomycin Solution (100X), 
cell counting kit-8, cell lysis buffer for Western 
and IP, BCA protein assay kit, BeyoECL Plus, 2-
(4-Amidinophenyl)-6-indolecarbamidine 
dihydrochloride (DAPI), horseradish-peroxidase 
(HRP) -labeled goat anti-rabbit IgG (H+L) were 
purchased from Beyotime (Haimen, China); 
cleaved-caspase-3 (c-caspase-3), cleaved-
caspase-9 (c-caspase-9) antibodies were 
purchased from Cell Signaling Technology 
(Beverly, MA, USA); Bcl-2, Bax and β-actin 
antibodies were purchased from Abcam 
Biotechnology (Cambridge, MA, USA); all other 





Immortalized human cervical cells (HeLa cells) 
were obtained from the Shanghai cell bank of 
Chinese academy of sciences (Shanghai, 
China). Cells were cultured in DMEM medium 
supplemented with 10 % FBS and antibiotics 
(100 U/mL penicillin G and 100 mg/mL of 
streptomycin) and maintained in a humidified 
atmosphere containing 5 % CO2 at 37 ºC. 
 
Cell viability assay by CCK-8 
 
Cell viability was carried out using the CCK-8 
assay. In Brief, HeLa cells were cultured until 
they reached approximately 90 % confluency 
before preparing the plates for the cell viability 
assay. Cells were seeded in 96-well plates at 5 × 
103 cells per well and grown for 24 h. Then, cells 
were treated with various concentrations of PSG 
(5, 10, 20, 40, 60, 80 and 100 μg/mL) for 24 h 
and then the cell proliferation inhibition was 
determined by CCK-8 following the 
manufacturer’s instructions. Optical density 
values (OD) were measured at 570 nm by a 
microplate reader (Bio-Rad, CA, USA) and the 
IC50 value of PSG on HeLa cells was calculated. 
Furthermore, for determining the time-dependent 
manner, Hela cells were treated with PSG (40 
μg/mL) for 12, 24, 36, 48, and 72 h, respectively; 
then, CCK-8 assay was used to determine the 
cell proliferation inhibition. The inhibition rate was 
calculated according to Eq 1.  
 
Inhibition (%) = {(Ac – At)/Ac}100 …………. (1) 
 
where Ac and At are the absorbance of control 
and treated samples, respectively. 
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Xenograft model of nude mice 
 
The antitumor effect of PSG in vivo was 
evaluated with the animal tumor model by 
inoculation of HeLa cells as previously reported 
[14]. BALB/C nude mice were randomly divided 
into control group (0.5 % DMSO, 0.1 mL/10g) 
and PSG treatment group (10, 20, and 40 
mg/kg/d, i.p.), each group contained 5 mice. 
Nude mice (18-22 g) were injected 
subcutaneously in the right flank with HeLa cells 
(2.0 × 106/mouse).  
 
When the tumor grew to approximately 2 – 3 mm 
in diameter, mice were treated with various 
concentrations of PSG (intraperitoneal injection, 
i.p.) and equal volume of solvent control (0.5 % 
DMSO, i.p.), respectively. Drugs were treated for 
consecutive 15 days and tumor sizes (width and 
length) were measured at 0, 5, 8, 12 and 15 
days. Finally, the tumor volumes were 
determined using the formula: volume = (width2 × 
length)/2. 
 
Nuclear staining with DAPI 
 
Cell apoptosis analysis was determined by DAPI 
staining assay. About 1 × 105 HeLa cells per well 
were cultured in 12-well plates and were treated 
with PSG (20, 40 and 60 μg/mL) for 24 h. Then, 
cells were stained with 10 μg/mL of DAPI for 10 
min at 37 °C, in the dark. Finally, the changes in 
the cells’ nucli were observed with a 
fluorescence microscope (Olympus, IX53, Tokyo, 
Japan). 
 
Western blot assay 
 
HeLa cells (1 x 106 cells/flask) were seeded in T-
25 flasks and were treated with PSG 20, 40 and 
60 μg/mL of PSG, then 24 h later, cells were 
harvested and total proteins were extracted with 
cell lysis buffer for western and IP. Subsequently, 
the protein concentration was determined by the 
BCA protein assay kit. Then, equal amount of 
total protein (40 μg) were separated by the 
sodium dodecyl sulfate polyacrylamide gel 
electrophoresis (SDS/PAGE). After that, all 
proteins were transferred to PVDF membranes 
and probed withcaspase-3, caspase-9, Bax, Bcl-
2 and β-actin monoclonal antibodies, 
respectively. After 12 h of incubation at 4 °C, 
HRP labeled secondary antibody was added and 
incubated for 2 h at 37 °C. Finally, protein bands 
were detected by Beyo ECL Plus kit 
(chemiluminescence). To normalize for protein 
loading, the Bio-Rad quantity one software was 
used to quantify the blot density and the proteins 
expression levels were expressed as a relative 




All values are represented as mean ± standard 
deviation (SD, n = 3). Statistical analysis was 
performed by two-tailed Student’s t-test using 
SPSS 19.0 software, and differences were 




Inhibitory effect of PSG on cervical cancer in 
vitro 
 
The anti-cervical cancer activity of PSG was 
determined by CCK-8 in HeLa cells. As can be 
seen from Fig 2A, PSG exhibited significant anti-
proliferative effects in concentration-dependent 
manner on HeLa cell, and the IC50 value was 
41.34 μg/mL. Furthermore, the anti-proliferative 
effect of PSG was also time-dependent (Fig 2B). 
 
 
Figure 2: Inhibitory effect of PSG on proliferation of Hela cells in vitro. (A) Cells were treated with PSG at 5, 10, 
20, 40, 60, 80 and 100 μg/mL for 24 h; then, CCK-8 assay was used to determine the cell proliferation inhibition 
(%, n = 4). (B) Cells were treated with 40μg/mL PSG for 12, 24, 36, 48, and 72 h, respectively; then, CCK-8 
assay was used to determine the cell proliferation inhibition (%) (n = 4) 
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Inhibitory effect of PSG on cervical cancer in 
vivo 
 
To further explore the anti-cervical cancer activity 
of PSG in vivo, PSG treatment was performed in 
the nude mouse xenograft model with HeLa 
cells. As shown in Fig 3, PSG (10, 20 and 40 
mg/kg, ip) significantly reduced tumor volume as 
compared to the solvent control group (p < 0.05, 
p < 0.01, p < 0.01), especially at dose of 40 
mg/kg and at day 15. 
 
Pro-apoptotic effect of PSG on HeLa cell 
 
According to the results above, PSG showed 
obvious anti-tumor activity on the human cervical 
cancer cell in vitro and in vivo. To explore 
whether the anti-tumor activity of PSG was 
related to apoptosis, HeLa cells were stained 
with DAPI. As shown in Fig 4, after treatment 
with PSG (20, 40, 60 μg/mL), cells exhibited 
obvious apoptosis features such as improved 
brightness, nuclear condensation and nuclear 
fragmentation. This result suggested that the 
anti-proliferative effect of PSG might be related 
to induction of apoptosis. 
 
Effect of PSG on protein expression of 
caspase-3, caspase-9, Bax, Bcl-2 in HeLa cell 
 
To further investigate the possible mechanism by 
which PSG induces apoptosis in HeLa cells,C-
caspase-3, C-caspase-9, Bcl-2 and Bax protein 
expression levels were studied by western blot. 
As shown in Fig 5, there was significant 
difference between untreated HeLa cells and 
PSG treatment group for all these protein 
expressions. Interestingly, compared to the 
control group, the protein expression levels of 
Caspase-3, Caspase-9 and Bax were gradually 
up-regulated with increased concentrations of 
PSG (20, 40, 60 μg/mL, p < 0.05, p < 0.01, p < 
0.01, respectively), whereas Bcl-2 protein 
expression was down-regulated significantly (p < 




To the best of our knowledge, this study is the 
first report regarding the antitumor effect of PSG 
on human cervical cancer cell line in vitro and in 
vivo. Furthermore, we first investigated the 
possible mechanisms of PSG on human cervical 
cancer cell line HeLa in our present study. The 
findings of the present study showed that PSG 
significantly inhibited cell proliferation in 
concentration-and time-dependent manners in 
HeLa cells. And PSG also reduced the tumor 
growth in nude mouse xenograft model with 
HeLa cells in a dose-dependent manner. In 
addition, we also found that exposure of HeLa 
cells to PSG leads to a marked increase in 
apoptosis, indicating that apoptosis contributes to 
growth inhibition in PSG-treated HeLa cells. 
 
Apoptosis, known as programmed cell death 
(PCD), is important for both health and disease 
and is one of the major mechanisms of cell death 
in response to cancer therapies [5,15]. Apoptosis 
mechanisms are highly complex. It is recognized 
that apoptosis is mediated by the extrinsic (death 
receptor) pathway, intrinsic (mitochondrial) 
pathway, and perforin/granzyme pathway [15]. 
 
Figure 3: Effect of PSG on Hela cells in vivo. BALB/C nude mice were inoculated subcutaneously with Hela cells 
(2 × 106 /mouse). Mice were randomized into control group (0.5% DMSO, 0.1 mL/10g) and PSG treatment group 
(10, 20, and 40 mg/kg/d, i.p.), each group contained 5 mice. Drugs were administered for consecutive 15 days 
after the tumors grew to approximately 2 – 3 mm in diameter. Data were expressed as mean ± SD; *p < 0.05, **p 
< 0.01, compared with control mice 
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Figure 4: Apoptotic effects of PSG on Hela cells by DAPI staining. Cells were treated with PSG (20, 40 and 60 
μg/mL) for 24 h, and the apoptotic cells were detected by DAPI staining and visualized under a fluorescent 




Figure 5: Effects of PSG on expressions of Bcl-2, Bax and caspase family of proteins. Cells were treated with 
PSG for 24 h; then, the total proteins were extracted and subjected to western blot analysis using antibodies 
against Bax, Bcl-2, C-caspase-3, C-caspase-9, and β-actin was used an internal control. Data were expressed as 
mean ± SD (n = 4), and asterisk indicated significant difference, *p < 0.05, **p < 0.01 
 
Each pathway is initiated by its own signalling 
molecules like caspases. For example, the 
extrinsic, intrinsic and granzyme B pathways can 
be initiated by caspase-8, caspase-9 and 
casepase-10, respectively. Once caspases are 
activated, the apoptotic signaling pathway will be 
activated resulting in cell death. Caspase-3 is the 
most important effector or executioner of the 
extrinsic, intrinsic and granzyme B pathway 
[15,16]. In our experiment, PSG significantly 
increased the protein expression of cleaved-
caspase-3 and cleaved-caspase-9 in HeLa cells, 
which indicated that the PSG-induced apoptosis 
process is due to activation of the mitochondrial 
pathway.  
 
Furthermore, it has been reported that the Bcl-2 
family of proteins play a critical role in control and 
regulation of mitochondrial mediated apoptotic 
pathway, because the mitochondrial membrane 
permeability is governed by this family of proteins 
[17]. The Bcl-2 family proteins have pro-apoptotic 
and anti-apoptotic effects. Bax is a critical pro-
apoptotic protein while Bcl-2 is an important anti-
apoptotic protein [18]. Bcl-2 is an integral 
membrane protein, which causes anti-apoptosis 
mainly by preventing mitochondrial outer 
membrane permeabilization. However, if the 
effect of Bcl-2 is suppressed, Baxoligomerization 
takes place and thus leads to apoptosis. 
Activation of Bax can result in the release of the 
contents of the mitochondrial inter-membrane 
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space, which then activates caspases and leads 
to a series of cascade reactions that result in cell 
death [17]. Our results demonstrated that 
exposure of PSG to HeLa cells leads to up-





The findings of the present study suggest that 
PSG possesses antitumor effect against human 
cervical cancer cell line by inducing 
mitochondrial-mediated apoptosis via up-
regulation of caspase-3, caspase-9 and Bax, as 
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